185 related articles for article (PubMed ID: 33478544)
1. Individualized quality of life benefit and cost-effectiveness estimates of proton therapy for patients with oropharyngeal cancer.
Brodin NP; Kabarriti R; Schechter CB; Pankuch M; Gondi V; Kalnicki S; Garg MK; Tomé WA
Radiat Oncol; 2021 Jan; 16(1):19. PubMed ID: 33478544
[TBL] [Abstract][Full Text] [Related]
2. A Quantitative Clinical Decision-Support Strategy Identifying Which Patients With Oropharyngeal Head and Neck Cancer May Benefit the Most From Proton Radiation Therapy.
Brodin NP; Kabarriti R; Pankuch M; Schechter CB; Gondi V; Kalnicki S; Guha C; Garg MK; Tomé WA
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):540-552. PubMed ID: 30496877
[TBL] [Abstract][Full Text] [Related]
3. Optimizing oropharyngeal cancer management by using proton beam therapy: trends of cost-effectiveness.
Li G; Xia YF; Huang YX; Okat D; Qiu B; Doyen J; Bondiau PY; Benezery K; Gao J; Qian CN
BMC Cancer; 2021 Aug; 21(1):944. PubMed ID: 34419008
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of proton beam therapy for treatment decision making in paranasal sinus and nasal cavity cancers in China.
Li G; Qiu B; Huang YX; Doyen J; Bondiau PY; Benezery K; Xia YF; Qian CN
BMC Cancer; 2020 Jun; 20(1):599. PubMed ID: 32590957
[TBL] [Abstract][Full Text] [Related]
5. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus Proton Therapy for Oropharyngeal Squamous Cell Carcinoma.
Sher DJ; Tishler RB; Pham NL; Punglia RS
Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):875-882. PubMed ID: 29976499
[TBL] [Abstract][Full Text] [Related]
6. Protons in head-and-neck cancer: bridging the gap of evidence.
Ramaekers BL; Grutters JP; Pijls-Johannesma M; Lambin P; Joore MA; Langendijk JA
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1282-8. PubMed ID: 23273998
[TBL] [Abstract][Full Text] [Related]
7. Intensity-modulated proton radiation therapy as a radical treatment modality for nasopharyngeal carcinoma in China: Cost-effectiveness analysis.
Li G; Xia YF; Huang YX; Okat D; Qiu B; Doyen J; Bondiau PY; Benezery K; Gao J; Qian CN
Head Neck; 2022 Feb; 44(2):431-442. PubMed ID: 34837286
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of intensity-modulated radiotherapy in oropharyngeal cancer.
Yong JH; Beca J; O'Sullivan B; Huang SH; McGowan T; Warde P; Hoch JS
Clin Oncol (R Coll Radiol); 2012 Sep; 24(7):532-8. PubMed ID: 22739256
[TBL] [Abstract][Full Text] [Related]
9. Dosimetric advantages of intensity-modulated proton therapy for oropharyngeal cancer compared with intensity-modulated radiation: A case-matched control analysis.
Holliday EB; Kocak-Uzel E; Feng L; Thaker NG; Blanchard P; Rosenthal DI; Gunn GB; Garden AS; Frank SJ
Med Dosim; 2016; 41(3):189-94. PubMed ID: 27158021
[TBL] [Abstract][Full Text] [Related]
10. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
[TBL] [Abstract][Full Text] [Related]
12. Making a case for high-volume robotic surgery centers: A cost-effectiveness analysis of transoral robotic surgery.
Rudmik L; An W; Livingstone D; Matthews W; Seikaly H; Scrimger R; Marshall D
J Surg Oncol; 2015 Aug; 112(2):155-63. PubMed ID: 26171771
[TBL] [Abstract][Full Text] [Related]
13. Two-year and lifetime cost-effectiveness of intensity modulated radiation therapy versus 3-dimensional conformal radiation therapy for head-and-neck cancer.
Kohler RE; Sheets NC; Wheeler SB; Nutting C; Hall E; Chera BS
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(4):683-9. PubMed ID: 24138916
[TBL] [Abstract][Full Text] [Related]
14. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
Shepherd J; Jones J; Takeda A; Davidson P; Price A
Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
[TBL] [Abstract][Full Text] [Related]
15. Intensity-modulated radiation therapy (IMRT) versus 3-dimensional conformal radiation therapy (3D-CRT) for head and neck cancer: cost-effectiveness analysis.
Marta GN; Weltman E; Ferrigno R
Rev Assoc Med Bras (1992); 2018 Apr; 64(4):318-323. PubMed ID: 30133610
[TBL] [Abstract][Full Text] [Related]
16. Costs and expected gain in lifetime health from intensive care versus general ward care of 30,712 individual patients: a distribution-weighted cost-effectiveness analysis.
Lindemark F; Haaland ØA; Kvåle R; Flaatten H; Norheim OF; Johansson KA
Crit Care; 2017 Aug; 21(1):220. PubMed ID: 28830479
[TBL] [Abstract][Full Text] [Related]
17. Upfront treatment of locally advanced cervical cancer with intensity modulated radiation therapy compared to four-field radiation therapy: a cost-effectiveness analysis.
Lesnock JL; Farris C; Beriwal S; Krivak TC
Gynecol Oncol; 2013 Jun; 129(3):574-9. PubMed ID: 23500086
[TBL] [Abstract][Full Text] [Related]
18. Using decision analysis to determine the cost-effectiveness of intensity-modulated radiation therapy in the treatment of intermediate risk prostate cancer.
Konski A; Watkins-Bruner D; Feigenberg S; Hanlon A; Kulkarni S; Beck JR; Horwitz EM; Pollack A
Int J Radiat Oncol Biol Phys; 2006 Oct; 66(2):408-15. PubMed ID: 16887291
[TBL] [Abstract][Full Text] [Related]
19. Patient-specific bolus for range shifter air gap reduction in intensity-modulated proton therapy of head-and-neck cancer studied with Monte Carlo based plan optimization.
Michiels S; Barragán AM; Souris K; Poels K; Crijns W; Lee JA; Sterpin E; Nuyts S; Haustermans K; Depuydt T
Radiother Oncol; 2018 Jul; 128(1):161-166. PubMed ID: 28951008
[TBL] [Abstract][Full Text] [Related]
20. Cost-Effectiveness Analysis of Intensity Modulated Radiation Therapy Versus 3-Dimensional Conformal Radiation Therapy for Preoperative Treatment of Extremity Soft Tissue Sarcomas.
Richard P; Phillips M; Smith W; Davidson D; Kim E; Kane G
Int J Radiat Oncol Biol Phys; 2016 Jul; 95(3):999-1008. PubMed ID: 27130792
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
